COAL INDIA LAUNCHES THALASSEMIA BAL SEWA YOJANA (TBSY)-PHASE III

Coal India Ltd (CIL) launched Phase-III of its Thalassemia Bal Seva Yojana (TBSY) on World Thalassemia Day 2023, with a project outlay of Rs 30 crores. As many as 300 children suffering from Thalassemia are expected to receive Bone Marrow Transplant (BMT) assistance during this phase.

The Maharatna Company has also launched a dedicated patient-friendly web portal in Phase – III to make the online application in order to avail benefits of Thalassemia Bal Seva Yojana (TBSY), a flagship CSR scheme of Coal India.
Coal India extends financial assistance of up to Rs. 10 lakhs to each patient affected with Thalassemia, Aplastic Anemia and MUD (Matched Unrelated Donor) subject to their eligibility to avail benefits of the scheme.

Coal India Ltd is the first Central Public Sector Enterprise to use its CSR fund for curative treatment of children with Thalassemia and Aplastic Anemia with a total project outlay of Rs 70 crores. Phases I and II of ‘Thalassemia Bal Seva Yojana’ had benefitted 356 BMTs at a total project outlay of Rs 40 crores.

Coal India had launched first phase of Thalassemia Bal Seva Yojana (TBSY) in March 2017 as a high-investment CSR initiative within the overarching guiding framework of the Ministry of Health & Family Welfare, Government of India. Thalassemics India, an NGO that has been working in this sector for over 25 years, was hired as the liaison and coordinating partner. The scheme’s second phase was launched in October 2020. Starting with four hospitals in the first phase, the initiative is financing BMTs in 10 hospitals nationwide.

It is projected that more than 10,000 thalassemic children are born in India every year, putting a significant strain on healthcare resources.